Sanofi (SANp)
Euronext Paris • Healthcare
October 27, 2026 at 16:30 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every €100 in revenue, Sanofi keeps €3 as net profit.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Sanofi topped consensus on both the top and bottom line in the second fiscal quarter of 2026, reported on 2026-07-30, with revenue of EUR 12.300 billion against a EUR 11.310 billion estimate, +8.8%, and adjusted EPS of EUR 2.09 versus EUR 1.90, +10.0%. Revenue rose 14.6% to about EUR 12.3 billion from about EUR 10.7 billion a year ago, while gross margin held near 76% and operating margin was about 19%. The quarter also generated about EUR 4.6 billion of operating cash flow and included about EUR 4.9 billion in dividends. For the next period, consensus calls for EPS of EUR 2.89 on revenue of EUR 13.172 billion.
Next report — what to expect
Sanofi (SAN.PA) reports earnings on October 30, 2026. The next-period consensus calls for EPS of EUR 2.88 on revenue of EUR 13.19 billion. For trailing context, revenue grew +14.6% year over year last quarter. Sanofi has beaten EPS in 5 of 8 most recent quarters.
About Sanofi
Sanofi is a healthcare company listed on Euronext Paris under SAN.PA that researches, develops, manufactures, and commercializes therapeutic solutions across prescription medicines, vaccines, and consumer health products. In FY2025, the group generated EUR 43.6 billion in revenue through a business that spans the United States, Europe, and other international markets.
Today's Snapshot
SANp closed 1.1% above yesterday's close, while its sector was flat. Volume was about a quarter of its usual level. Sanofi shifted toward buying drugs close to approval as key patents near expiry.
Trading Volume
Below 10d avg (2.0M)
395.6K
vs S&P 500 Today
Outperforming Market
+0.70%
Updated: October 27, 2026 at 15:07 UTC
SANp Headlines
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$73.13 - $77.23Buy
- RSI (14)59.47Neutral
- Stochastic %K (14, 3, 3)88.24Sell
- MACD Level (12, 26)0.27Buy
Peers & Related Assets
Get premium market insights delivered directly to your inbox.